Prothena Plc Correlations
| PRTA Stock | USD 9.03 0.06 0.66% |
The current 90-days correlation between Prothena plc and Kalvista Pharmaceuticals is 0.38 (i.e., Weak diversification). The correlation of Prothena Plc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Prothena Plc Correlation With Market
Excellent diversification
The correlation between Prothena plc and DJI is -0.69 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Prothena plc and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Prothena Stock
| 0.67 | VCYT | Veracyte Earnings Call This Week | PairCorr |
| 0.77 | DRMA | Dermata Therapeutics Buyout Trend | PairCorr |
| 0.76 | DTIL | Precision BioSciences | PairCorr |
Moving against Prothena Stock
| 0.76 | DRTS | Alpha Tau Medical | PairCorr |
| 0.74 | EQ | Equillium | PairCorr |
| 0.61 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.56 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.48 | VERA | Vera Therapeutics | PairCorr |
| 0.44 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.42 | VALN | Valneva SE ADR | PairCorr |
| 0.39 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.36 | DSGN | Design Therapeutics | PairCorr |
| 0.35 | PYC | Physiomics Plc | PairCorr |
| 0.69 | 0P6S | Bayer AG NA | PairCorr |
| 0.67 | VTVT | vTv Therapeutics Downward Rally | PairCorr |
| 0.64 | DVAX | Dynavax Technologies | PairCorr |
| 0.64 | VNDA | Vanda Pharmaceuticals | PairCorr |
| 0.58 | ALA | Arovella Therapeutics Earnings Call This Week | PairCorr |
| 0.56 | VRTX | Vertex Pharmaceuticals | PairCorr |
| 0.55 | SRZNW | Surrozen Warrant | PairCorr |
| 0.52 | S09 | Sutro Biopharma Split | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Prothena Stock performing well and Prothena Plc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Prothena Plc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KALV | 3.09 | 0.31 | 0.07 | 0.40 | 3.62 | 6.19 | 20.72 | |||
| BCYC | 2.66 | (0.29) | 0.00 | (0.16) | 0.00 | 6.06 | 14.20 | |||
| FDMT | 3.80 | (0.07) | 0.00 | 0.10 | 0.00 | 7.04 | 27.09 | |||
| VSTM | 3.59 | 0.00 | 0.00 | 0.00 | 0.00 | 6.21 | 29.76 | |||
| OLMA | 6.27 | 2.71 | 0.62 | (0.74) | 2.88 | 9.82 | 145.73 | |||
| VTYX | 3.34 | 0.81 | 0.17 | (1.37) | 3.21 | 9.00 | 37.04 | |||
| NMRA | 4.25 | 0.53 | 0.12 | 0.86 | 3.61 | 10.98 | 33.25 | |||
| CRVS | 6.64 | 2.68 | 0.53 | (0.34) | 3.26 | 9.63 | 174.42 | |||
| GOSS | 3.87 | (0.15) | 0.00 | 4.05 | 0.00 | 8.77 | 27.11 | |||
| RIGL | 3.02 | (0.10) | 0.00 | (0.08) | 0.00 | 6.30 | 20.01 |
Prothena Plc Corporate Management
| Hideki MD | Chief Officer | Profile | |
| CPA CPA | Chief Controller | Profile | |
| Jennifer Zibuda | Director Communication | Profile | |
| Brandon Smith | Chief Officer | Profile | |
| Wagner Zago | Chief Scientific Officer | Profile | |
| Carol Karp | Chief Regulatory Officer | Profile | |
| David Ford | Chief Officer | Profile |